Ana Bettencourt

Dr. Ana Bettencourt

Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MSMariana Silva
Mariana Silva
RCRaquel Calado
Raquel Calado
Joana MartoJoana Marto
Joana Marto
Ana BettencourtAna Bettencourt
Ana Bettencourt
AAAntonio Almeida
Antonio Almeida
Luís Miguel GoncalvesLuís Miguel Goncalves
Luís Miguel Goncalves
Pharmaceutical approaches based on nanotechnologies and the development of eye drops composed of the mucoadhesive polymers chitosan and hyaluronic acid are emerging strategies for the efficient treatment of ocular diseases. These innovative nanoparticulate systems aim to increase drugs’ bioavailability at the ocular surface. For the successful development of these systems, the evaluation of mucoahesiveness (the interaction between the ocular delivery system and mucins present on the eye) is of utmost importance. In this context, the aim of the present work was to investigate the mucoadhesivity of a novel nanoparticle eye drop formulation containing an antibiotic (ceftazidime) intended to treat eye infections. Eye drop formulations comprised a polymer (hydroxypropyl) methyl cellulose (HPMC) 0.75% (w/v) in an isotonic solution incorporating chitosan/sodium tripolyphosphate (TPP)-hyaluronic acid-based nanoparticles containing ceftazidime. The viscosity of the nanoparticles, and the gels incorporating the nanoparticles were characterized in contact with mucin at different mass ratios, allowing the calculation of the rheological synergism parameter (∆η). Results showed that at different nanoparticle eye formulation:mucin weight ratios, a minimum in viscosity occurred which resulted in a negative rheological synergism. Additionally, the results highlighted the mucoadhesivity of the novel ocular formulation and its ability to interact with the ocular surface, thus increasing the drug residence time in the eye. Moreover, the in vitro release and permeation studies showed a prolonged drug release profile from the chitosan/TPP-hyaluronic acid nanoparticles gel formulation. Furthermore, the gel formulations were not cytotoxic on ARPE-19 and HEK293T cell lines, evaluated by the metabolic and membrane integrity tests. The formulation was stable and the drug active, as shown by microbiological studies. In conclusion, chitosan/TPP-hyaluronic acid nanoparticle eye drop formulations are a promising platform for ocular drug delivery with enhanced mucoadhesive properties.

1 May 2010 in Dental Materials
Verified
Journal Article
Closed access
Ana BettencourtAna Bettencourt
Ana Bettencourt
CNCristina Bettencourt Neves
Cristina Bettencourt Neves
MAMarise S. de Almeida
Marise S. de Almeida
LPLídia Maria Pinheiro
Lídia Maria Pinheiro
SOSofia Arantes e Oliveira
Sofia Arantes e Oliveira
MCMatilde F. Castro
Matilde F. Castro


18 January 2012 in Journal of Microencapsulation
Verified
Journal Article
Closed access
Ana BettencourtAna Bettencourt
Ana Bettencourt
AAAntonio Almeida
Antonio Almeida
Poly(methyl methacrylate) (PMMA) is one of the most widely explored biomedical materials because of its biocompatibility, and recent publications have shown an increasing interest in its applications as a drug carrier. PMMA-based particulate carriers (PMMAP) can be prepared either by polymerization methods or from pre-formed polymer-based techniques. Potential biomedical application of these particles includes their use as adjuvant for vaccines and carrier of many drugs as antibiotics and antioxidants via different routes of administration. Release of drugs from PMMAP occurs typically in a biphasic way with an incomplete drug release. To improve release profiles, recent strategies are focusing on increasing polymer hydrophilicity by synthesizing functionalized PMMA microspheres or by formulating PMMA composites with hydrophilic polymers. This review examines the current status of preparation techniques, drug release kinetics, biomedical applications and toxicity of these nano/micro PMMA-based particulate carriers.

1 January 2018 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Victor MartinVictor Martin
Victor Martin
Ana BettencourtAna Bettencourt
Ana Bettencourt

16 November 2022 in Polymers
Verified
Journal Article
Open access
PDF file
SRSofia Romão
Sofia Romão
Ana BettencourtAna Bettencourt
Ana Bettencourt
Isabel RibeiroIsabel Ribeiro
Isabel Ribeiro
Packaging plays an important role in food quality and safety, especially regarding waste and spoilage reduction. The main drawback is that the packaging industry is among the ones that is highly dependent on plastic usage. New alternatives to conventional plastic packaging such as biopolymers-based type are mandatory. Examples are cellulose films and its derivatives. These are among the most used options in the food packaging due to their unique characteristics, such as biocompatibility, environmental sustainability, low price, mechanical properties, and biodegradability. Emerging concepts such as active and intelligent packaging provides new solutions for an extending shelf-life, and it fights some limitations of cellulose films and improves the properties of the packaging. This article reviews the available cellulose polymers and derivatives that are used as sustainable alternatives for food packaging regarding their properties, characteristics, and functionalization towards active properties enhancement. In this way, several types of films that are prepared with cellulose and their derivatives, incorporating antimicrobial and antioxidant compounds, are herein described, and discussed.